Delivery Order SPE2DR25D9239-SPE2DR26FFCD6
Award Date 2/23/26
Potential Completion Date 2/24/26
Potential Value $6.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $4,690.14 delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting recurring pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is...
- The Defense Logistics Agency issued a $1,617.78 delivery order to DMS Pharmaceutical Group Inc. on February 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract supporting recurring pharmaceutical supply needs for Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned...
- The Defense Logistics Agency issued a $1,737.68 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 17, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency program that authorizes firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and...
- The Defense Logistics Agency issued a $4,764.20 delivery order to DMS Pharmaceutical Group Inc. on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract program supporting recurring pharmaceutical supply needs of military healthcare facilities worldwide. The program encompasses branded and generic prescription...
- The Defense Logistics Agency issued a $1,139.80 delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract program supporting Department of Defense healthcare operations globally with firm fixed-price delivery orders for branded and generic prescription drugs,...
- The Defense Logistics Agency issued a $12,720.92 delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to...
- The Defense Logistics Agency issued a $1,525.41 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 22, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics,...
- The Defense Logistics Agency issued a $4,173.45 delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical supply to Department of Defense healthcare facilities worldwide, with a $499.999 billion ceiling and completion date of December 31, 2036. The contract authorizes...
- The Defense Logistics Agency issued a $1,179.38 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to federal military healthcare facilities. The PPV-G GEN V is a Defense Logistics Agency-administered indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines,...
- The Defense Logistics Agency issued a $1,388.44 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 6, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical supply to federal agencies. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines,...